Adjuvant Global Health Technology Fund, L.P.

Shareholder at ANTX

Sold, on record
$1.7M
Dollars the filings state
Form 4 sales
2
Latest Oct 2, 2023
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ANTXAN2 Therapeutics, Inc.Shareholder

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ANTXNo plan
    Sep 13, 2023 2023

    Sold 400 shares at $16.00 ($6k)

    Adjuvant Global Health Technology Fund, L.P., 10% owner

    No 10b5-1 planSold 0% of holdings ($34.8M position)2.2M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ANTXNo plan
    Oct 2, 2023 +19 days

    Sold 104,773 shares at $16.27 ($1.7M)

    Adjuvant Global Health Technology Fund, L.P., 10% owner

    No 10b5-1 planSold 4.8% of holdings ($35.6M position)2.1M shares leftFiling

  3. 3 Form 144 notice ANTXNotice
    Jan 16, 2024 +106 days

    Filed to sell 84,093 shares ($1.8M)

    Adjuvant Global Health Technology Fund, L.P., Shareholder

    No 10b5-1 planFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Adjuvant Global Health Technology Fund, L.P.
Source
Jan 16, 2024Jan 16, 2024ANTXShareholderForm 144 notice84,093$1.8MNoticeSEC
Oct 2, 2023Oct 3, 2023ANTX10% ownerForm 4 sale104,773$1.7M4.8%No planSEC
Sep 13, 2023Sep 15, 2023ANTX10% ownerForm 4 sale400$6k0.0%No planSEC